AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27329612
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of glucose beverage (control)
Trial: 27329612
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of soft drink
Trial: 27329612
Drug: 355 ml
RxNorm normalized name: ALCOHOL 141.5 g in 355 mL TOPICAL SPRAY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 355 ml of soft drink
Trial: 25007689
Drug: Intrathecal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal fentanyl 25 microg plus 3 ml of 0.5% hyperbaric bupivacaine (Group BF)
Trial: 25007689
Drug: Intrathecal tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal tramadol 25 mg plus 3 ml of 0.5% hyperbaric bupivacaine (Group BT)
Trial: 10418894
Drug: Simultaneously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneously administered influenza and pneumococcal vaccines
Trial: 23800161
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg infusion every 12 h
Trial: 23800161
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg infusion followed by continuous infusion at 8 mg/h
Trial: 23800161
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg infusion followed by continuous infusion at 4 or 8 mg/h
Trial: 21670453
Drug: Palifermin (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palifermin (180 μg/kg) administered before chemoradiotherapy and once weekly for 7 weeks
Trial: 11745911
Drug: 375-mg oral
RxNorm normalized name: cefaclor 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375-mg oral dose of linezolid (tablets) while fasting
Trial: 9417761
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of rhenium‐186 combined with triamcinolonhexacetonid (group 1)
Trial: 9417761
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of erbium‐169 combined with triamcinolonhexacetonid (group 3)
Trial: 9417761
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of triamcinolonhexacetonid alone (group 4)
Trial: 8518353
Drug: Diet B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet B (low calorie daily menus)
Trial: 23176879
Drug: Propranolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (10 mg or 20 mg)
Trial: 23176879
Drug: Salbutamol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (5 mg nebulized)
Trial: 19836153
Drug: 40 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 Gy in 20 twice‐daily fractions (Arm A)
Trial: 19836153
Drug: 20 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 Gy in four daily fractions (Arm B)
Trial: 8922358
Drug: Glomerular normofiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glomerular normofiltration (GFR 83‐135 ml x min(‐1) x 1.73 m(‐2))
Trial: 8922358
Drug: Glomerular hyperfiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glomerular hyperfiltration (GFR >135 ml x min(‐1) x 1.73 m(‐2))
Trial: 1319875
Drug: Maalox 70
RxNorm normalized name: Maalox
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox 70 (antacid)
Trial: 17578485
Drug: Domperidone 40
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 40 mg
Trial: 6375874
Drug: Domperidone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (all doses)
Trial: 31604480
Drug: At least
RxNorm normalized name: Lovaza 1000 MG (at least 900 MG) Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: At least Twice Daily (ALTD) screening
Trial: 20569031
Drug: Aloe vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera cream
Trial: 17251214
Drug: Oral pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral pregabalin (titrated to 300 mg)
Trial: 17251214
Drug: Aprepitant (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (titrated to 320 mg)
Trial: 17251214
Drug: Pregabalin +
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin + parecoxib (40 mg)
Trial: 17251214
Drug: Aprepitant +
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant + parecoxib (40 mg)
Trial: 9603635
Drug: Ceftazidime (10-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (10-30 mg/kg t.i.d. i.v.)
Trial: 7802179
Drug: 27 G
RxNorm normalized name: SODIUM CHLORIDE 0.027 g in 3 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 27 G Whitacre needle
Trial: 16753947
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg melatonin (Melaxen) daily at 22:30 h for 2 weeks
Trial: 12042193
Drug: Risperidone plus
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone plus 400 mg/day of celecoxib
Trial: 946580
Drug: Intravenous cortisol
RxNorm normalized name: Corticool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cortisol (1,000 mg)
Trial: 946580
Drug: Intramuscular betamethasone
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular betamethasone (12.0 mg)
Trial: 25110847
Drug: Medication beliefs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication beliefs
Trial: 21648282
Drug: Collagen +
RxNorm normalized name: Walgreens Ultra Collagen + Vitamin C 2500mg-60mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen + Calcium (G-III, n=22)
Trial: 15315591
Drug: Prophylactic antithrombotic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antithrombotic treatment
Trial: 9447569
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba special extract EGb 761 (240 mg/day)
Trial: 3258200
Drug: Intravenous polymyxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous polymyxin B for 5 days in addition to standard therapy
Trial: 25418186
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 mg (withdrawal)
Trial: 25418186
Drug: Tofacitinib 10
RxNorm normalized name: tofacitinib 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 10 mg (withdrawal)
Trial: 3912182
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 mg)
Trial: 3912182
Drug: Placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10 mg)
Trial: 3903970
Drug: S-carboxy-methyl-L-cysteine, 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-carboxy-methyl-L-cysteine, 750 mg three times daily for three days before examination
Trial: 24840511
Drug: sn-2+3 g/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sn-2+3 g/L OF
Trial: 24840511
Drug: sn-2+5 g/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sn-2+5 g/L OF
Trial: 22607546
Drug: Tailored treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored treatment (T)
Trial: 19256057
Drug: Antibacterial treatment
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibacterial treatment plus wardenafil (10 mg in the evening)
Trial: 19256057
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (fluoroquinolone + wardenafil)
Trial: 11192957
Drug: Nebulized fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized fluticasone propionate (1 mg b.d.)
Trial: 11192957
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (2 mg kg(‐1) day(‐1) for 4 days then 1 mg kg(‐1) day(‐1) for 3 days)
Trial: 9198507
Drug: No fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No fluid or solids for at least four hours before the injection (Group A, 499 cases)
Trial: 28510679
Drug: Intra-articular triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular triamcinolone (40 mg every 12 weeks for 2 years)
Trial: 26241420
Drug: Placebo (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (200 micrograms folic acid twice a day)
Trial: 23810050
Drug: Low‐viscosity light‐cured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐viscosity light‐cured resin infiltration after enamel conditioning with a 15% HCl gel
Trial: 21138531
Drug: Transdermal buprenorphine
RxNorm normalized name: buprenorphine Transdermal System
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Transdermal buprenorphine (20 μg/hr, 144 hr)
Trial: 10793606
Drug: Gelofusine 500
RxNorm normalized name: Gelofusine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelofusine 500 ml over 15 min
Trial: 3993604
Drug: Milk with
RxNorm normalized name: BETTERMILK with Glytactin 10PE Powder for Suspension (Orange Creme)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk with thiocyanate concentration of 19 mg/l
Trial: 3993604
Drug: Milk with
RxNorm normalized name: BETTERMILK with Glytactin 10PE Powder for Suspension (Orange Creme)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk with thiocyanate concentration of 3.6 mg/l
Trial: 3993604
Drug: Milk with
RxNorm normalized name: BETTERMILK with Glytactin 10PE Powder for Suspension (Orange Creme)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk with iodine concentration of 0.1 mg/l and thiocyanate concentration of 19 mg/l
Trial: 3993604
Drug: Milk with
RxNorm normalized name: BETTERMILK with Glytactin 10PE Powder for Suspension (Orange Creme)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk with iodine concentration of 0.1 mg/l and thiocyanate concentration of 3.6 mg/l
Trial: 19637777
Drug: Triple regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple regimen with vitamin C (20 mg Omeprazol, 1 g amoxicillin, 250 mg clarithromycin plus 250 mg vitamin C twice daily for 2 weeks)
Trial: 19637777
Drug: Triple regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple regimen without vitamin C (20 mg Omeprazol, 1 g amoxicillin, and 500 mg clarithromycin twice daily for 2 weeks)
Trial: 17605895
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg daily) and vitamin B complex for 3 months
Trial: 16355501
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg alendronate daily
Trial: 20490798
Drug: Dexamethasone 5
RxNorm normalized name: dexamethasone 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 5 mg/m²/day administered 30 min prior to etoposide infusion
Trial: 11436877
Drug: Singleton endocervical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Singleton endocervical application of 0.5 mg dinoprostone gel and intramuscular Prostin 15 M (Carboprost Tromethamine) (1 ml/2 h) administered 10 hours later until abortion
Trial: 11436877
Drug: Singleton double-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Singleton double-dose endocervical application of 0.5 mg dinoprostone gel and intramuscular Prostin 15 M (Carboprost Tromethamine) (1 ml/2 h) administered 10 hours later until abortion
Trial: 25277789
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg misoprostol sublingually after delivery of the newborn
Trial: 16459225
Drug: DAG meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAG meal (10 g of DAG oil)
Trial: 7556988
Drug: Nicotinamide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide (25 mg/kg body weight for 12 months)
Trial: 2025309
Drug: Ibuprofen and
RxNorm normalized name: Ibuprofen and Famotidine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen and Alprazolam
Trial: 19208305
Drug: Pressor arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressor arm (not specified treatment)
Trial: 17558683
Drug: Low-dose gonadotropin-releasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose gonadotropin-releasing hormone agonist (buserelin)
Trial: 1303630
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg administered 6-hourly
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with concurrent stereotactic radiation therapy (50 Gy in 4 fractions or 60 Gy in 10 fractions)
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with sequential stereotactic radiation therapy
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with concurrent stereotactic radiation therapy
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with stereotactic radiation therapy (sequential lung group)
Trial: 31658994
Drug: Low-dose radiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radiation to nontargeted lesions
Trial: 26520894
Drug: Mesoglycan (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesoglycan (60 mg, single i.m. administration)
Trial: 14695722
Drug: Nefopam at
RxNorm normalized name: nefopam
DrugBank: Nefopam (DB12293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam at a target plasma concentration of 70 ng/ml (high dose, approximately 20 mg total)
Trial: 14695722
Drug: Nefopam at
RxNorm normalized name: nefopam
DrugBank: Nefopam (DB12293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam at a target plasma concentration of 35 ng/ml (low dose)
Trial: 3033593
Drug: 10(4) PFU
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(4) PFU of vaccine virus
Trial: 24511715
Drug: Sublingual 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual 200 microg of misoprostol
Trial: 16409513
Drug: Coca-Cola treatment
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coca-Cola treatment for 2 hours
Trial: 16409513
Drug: Coca-Cola treatment
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coca-Cola treatment for 3 hours
Trial: 12942586
Drug: 7 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 g/day of inulin
Trial: 7506400
Drug: Argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon laser photocoagulation treatment
Trial: 483364
Drug: Levamisole 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole 2.5 mg/kg of body weight (90% coverage)
Trial: 483364
Drug: Levamisole 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole 2.5 mg/kg of body weight (60% coverage)
Trial: 483364
Drug: Levamisole 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole 2.5 mg/kg of body weight (40% coverage)
Trial: 28666680
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza vaccine by self-administered microneedle patch
Trial: 11819768
Drug: Omeprazole 2
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 2 X 20mg, clarithromycin 2 X 500mg, and amoxicillin 2 X 1g for 7 days
Trial: 8866631
Drug: Prazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (1 mg)
Trial: 1071692
Drug: Hydrallazine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrallazine (20 mg)
Trial: 24125402
Drug: simvastatin/ezetimibe 10/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: simvastatin/ezetimibe 10/10 mg
Trial: 17176348
Drug: Injection practices
RxNorm normalized name: Practical Alchemy Purify and Protect Duo KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection practices assessment
Trial: 3139179
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg twice daily
Trial: 2411103
Drug: Topical nasal
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nasal decongestants
Trial: 25524791
Drug: Systematic stimulant
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systematic stimulant treatment
Trial: 14513417
Drug: 5-drug salvage
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-drug salvage regimen after 12 weeks of structured treatment interruption (STI)
Trial: 14513417
Drug: 5-drug salvage
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-drug salvage regimen immediately (noninterruption [NI] group])
Trial: 10846380
Drug: Midazolam lollipop
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam lollipop (5 mg)
Trial: 10846380
Drug: Midazolam and
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam and atropine lollipop (5 mg midazolam and 0.25 mg atropine)
Trial: 3436155
Drug: Indomod (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomod (75 mg sustained-release indomethacin)
Trial: 3436155
Drug: Indocid R
RxNorm normalized name: Indocid R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indocid R (25 mg normal, 50 mg sustained-release indomethacin)
Trial: 18157013
Drug: Cytokine-induced killer
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cytokine-induced killer (CIK) cells therapy
Trial: 16979496
Drug: Single low-level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single low-level laser therapy (LLLT); Mini Laser 2075, Helbo Photodynamic Systems GmbH & Co KG, Linz, Austria; wavelength 670 nm, power output 75 mW; duration 30 seconds per banded tooth
Trial: 16979496
Drug: Placebo laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo laser therapy without active laser irradiation
Trial: 10930199
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LR) 1 L
Trial: 31531854
Drug: Fentanyl intravenous
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl intravenous patient-controlled analgesia
Trial: 22068809
Drug: combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combination of both
Trial: 30465369
Drug: Haemocoel preload
RxNorm normalized name: Haemaccel
DrugBank: Polygeline (DB15879)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemocoel preload (500 ml before spinal anaesthesia)
Trial: 26762672
Drug: PR-fampridine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PR-fampridine (10 mg, twice daily)
Trial: 22426704
Drug: Spinal exercise
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal exercise therapy and analgesics (Control group)
Trial: 18356664
Drug: 4 peritumoral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 peritumoral (PT) injections
Trial: 18356664
Drug: PT and
RxNorm normalized name: ZINC OXIDE 165 mg in 1 g TOPICAL STICK [Ciele Sculpt and Protect]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT and SD injection groups
Trial: 10482007
Drug: Clobetasol-17 propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly
Trial: 10482007
Drug: Clobetasol-17 propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobetasol-17 propionate ointment without an HCD twice daily
Trial: 6238338
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg paroxetine
Trial: 31295048
Drug: Women who
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women who received ≥1 dose of HPV vaccine
Trial: 31295048
Drug: Women who
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women who did not receive HPV vaccine (unvaccinated)
Trial: 12466341
Drug: Fluvastatin XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin XL 80 mg
Trial: 10703470
Drug: 12 G
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 G needle
Trial: 1897688
Drug: L-648,051 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-648,051 (800 micrograms) inhaled during the immediate phase (15 min after antigen challenge)